(NASDAQ:MGTX), LONDON and NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) — MeiraGTx Holdings Plc (Nasdaq: MGTX), a vertically integrated, clinical-stage genetic medicines company, today announced the U.S. Food and Drug Administration (FDA) has granted the Company Rare Pediatric Disease Designation to its AAV8-RK-RetGC program for the treatment of patients with Leber congenital amaurosis due to GUCY2D mutations […]

(NYSE MKT:AIM), Recently published article on study findings underscores links between study participants infected with SARS-CoV-2 and the incidence of ME/CFS The early-onset broad-spectrum antiviral effect of Ampligen has been observed to stimulate strong innate immune response, offering potential therapeutic benefits for people with ME/CFS or Post-COVID chronic fatigue OCALA, Fla., Jan. 22, 2025 (GLOBE

(NASDAQ:VMEO), PARK CITY, Utah, Jan. 22, 2025 (GLOBE NEWSWIRE) — Vimeo (NASDAQ: VMEO), the world's most innovative video experience platform for creators and enterprises, today announced its sponsorship of the Short Film Program at the Sundance Film Festival. These shorts will screen as part of eight curated Short Film Programs that will include fiction, nonfiction,

(NYSE MKT:SCPX), DURHAM, N.C., Jan. 22, 2025 (GLOBE NEWSWIRE) — Scorpius Holdings, Inc (NYSE American: SCPX) (“Scorpius” or “the Company”), an integrated contract development and manufacturing organization (“CDMO”), today announced its collaboration with KaloCyte, a pioneering pre-clinical company in the field of therapeutic innovation. Under this initial project, Scorpius will utilize its scientific and technical

(NASDAQ:ONCY),(TSX:ONC),(NYSE:GSK),(NYSE:BMY),(NASDAQ:GILD),(NASDAQ:AZN), PALM BEACH, Fla., Jan. 22, 2025 (GLOBE NEWSWIRE) — FN Media Group News Commentary – The demand for effective pancreatic cancer treatments is and has been undeniably high. The growing number of diagnoses, with the aggressive nature of the disease, fuels the market. This demand is further amplified by rising awareness and a focus

NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) — REEMAG LLC (“REEMAG” or the “Company”), a leader in sustainable rare earth magnet recycling, and a portfolio company of Cove Capital LLC, proudly announces a significant breakthrough in its mission to transform the rare earth magnet industry with low-carbon footprint solutions. The company has successfully scaled its

(NYSE:ARI), NEW YORK, Jan. 22, 2025 (GLOBE NEWSWIRE) — Apollo Commercial Real Estate Finance, Inc. (the “Company” or “ARI”) (NYSE:ARI), today announced the Company will hold a conference call to review its fourth quarter and full year 2024 financial results on Tuesday, February 11, 2025 at 10:00 a.m. Eastern Time. The Company's fourth quarter and

NORWALK, Conn., Jan. 22, 2025 (GLOBE NEWSWIRE) — CUSIP Global Services (CGS) today announced the launch of a new CUSIP service for the private credit market. Developed in conjunction with CGS operator FactSet Research Systems Inc. (FactSet), the new service improves transparency and efficiency in the rapidly growing direct lending space, which includes direct loans,

(NYSE:COHR), PITTSBURGH, Jan. 22, 2025 (GLOBE NEWSWIRE) — Coherent Corp. (NYSE: COHR) (the “Company”), a global leader in materials, networking, and lasers, announced today that it will release second-quarter fiscal 2025 financial results on Wednesday, February 5, after the New York Stock Exchange closes. The release will be followed by a live audio webcast at

(NASDAQ:BDRX), January 22, 2025 Biodexa Strengthens Management Team Appointment of Dr Gary A. Shangold as Chief Medical Officer Biodexa Pharmaceuticals PLC (“Biodexa” or “the Company”), (Nasdaq: BDRX), a clinical stage biopharmaceutical company developing a pipeline of innovative products for the treatment of diseases with unmet medical needs announced today the appointment of Dr Gary A.